Abstract microRNAs (miRNAs) regulate gene expression at the post-transcriptional level and they play an important role in various biological processes in the human body. Therefore, identifying their regulation mechanisms is essential for the diagnostics and therapeutics for a wide range of diseases. There have been a large number of researches which use gene expression profiles to resolve this problem. However, the current methods have their own limitations. Some of them only identify the correlation of miRNA and mRNA expression levels instead of the causal or regulatory relationships while others infer the causality but with a high computational complexity. To overcome these issues, in this study, we propose a method to identify miRNA-mRNA regulatory relationships in breast cancer using the invariant causal prediction. The key idea of invariant causal prediction is that the cause miRNAs of their target mRNAs are the ones which have persistent causal relationships with the target mRNAs across different environments. In this research, we aim to find miRNA targets which are consistent across different breast cancer subtypes. Thus, first of all, we apply the Pam50 method to categorise BRCA samples into different "environment" groups based on different cancer subtypes. Then we use the invariant causal prediction method to find miRNA-mRNA regulatory relationships across subtypes. We validate the results with the miRNA-transfected experimental data and the results show that our method outperforms the state-of-the-art methods. In addition, we also integrate this new method with the Pearson correlation analysis method and Lasso in an ensemble method to take the advantages of these methods. We then validate the results of the ensemble method with the experimentally confirmed data and the ensemble method shows the best performance, even comparing to the proposed causal method. Functional enrichment analyses show that miRNAs in the regulatory relationship predicated by the proposed causal method tend to synergistically regulate target genes, indicating the usefulness of these methods, and the identified miRNA targets could be used in the design of wet-lab experiments to discover the causes of breast cancer.
The human transcriptome is composed of 98% of non-coding RNAs (ncRNAs) and only 2 2% of protein-coding RNAs [1] . However, research into the roles of ncRNAs is still in 3 the early stage. The emergence of ncRNAs as new key players in cancer development 4 and progression has shifted our understanding of gene regulation [1, 2] , especially since 5 the discovery of microRNAs (miRNAs). miRNAs are short ncRNAs that regulate gene 6 expression at the post-transcriptional level and identified as the drivers in diverse 7 disease conditions including cancers, where they function either as oncogenes or as 8 tumour suppressors [3, 4] . Recent years have also seen the discovery of several other 9 types of ncRNAs, including long non-coding RNAs (lnRNAs), pseudogenes and circular 10 RNAs (cirRNAs), along with their regulatory functions in disease conditions [4] . There 11 also has been evidence that mRNAs, miRNAs, and other ncRNAs work in concert to 12 regulate cancer development and progression [5, 6] . 13 
14
There have been several methods developed to explore miRNA functions, including 15 those for predicting miRNA targets and regulatory modules (see [7] for a review), 16 inferring miRNA sponge networks and modules [6, [8] [9] [10] , and identifying cancer 17 subtypes [11] [12] [13] . However, our understanding of miRNAs' roles in regulating cancer 18 across different subtypes thereby permitting prognosis, diagnosis, and prediction of 19 therapy response is still very far from complete, and reliable methods for identifying 20 miRNA-mRNA regulatory relationships in cancer are in demand. 21 22 Existing computational methods for inferring miRNA-mRNA regulatory 23 relationships are of two major categories: sequence based approach and expression 24 based approach. The former is based on complementary base pairing, site accessibility, 25 and evolutionary conservation; and the latter relies on the negative correlation between 26 miRNA and mRNA expression levels. This expression-based approach can be further 27 divided into i) correlation-based approach [14] [15] [16] , and ii) causal inference 28 approach [17] [18] [19] . 29 30 Each of the approaches has its own advantages and limitations. The correlation and 31 regression based approaches [14] [15] [16] The algorithm for detecting miRNA-mRNA relationships includes three steps as the 78 followings.
79
Step 1: Select significant miRNAs and mRNAs. The matched miRNA and mRNA 80 expression samples are extracted from the breast adenocarcinoma (BRCA) dataset of function of CancerSubtypes package [11] to select miRNAs and mRNAs with the most 84 different Median Absolute Deviation (MAD). We select the top 30 miRNAs and top 85 1,500 mRNAs for our experiments so that other causal inference methods including 86 jointIDA or IDA could produce the results within a week for the purpose of comparison. 87 Step 2: Categorise samples into different experiment settings based on cancer 88 subtypes by using Pam50 [21] to discover miRNA targets across cancer subtypes.
89
Step 3: Estimate the causal relationship of miRNAs on mRNAs by estimating the InvariantCausalPrediction package [20] . The detail of this step is as the following. We use the similar notation as that in [20] . Let E be the set of environments. For an 100 environment e ∈ E, (X e , Y e ) is an independent and identically distributed (i. 
where µ is a constant intercept term, Hidden invariant causal predictation ICP has an extension for hidden variables. 112 The hidden ICP assumes that ∀e ∈ E :
113 X e has an arbitrary distribution,
114
where H are hidden variables, γ * ∈ R p are causal coefficients and g :
In this work, we propose to apply hidden ICP to discover miRNA-mRNA regulatory 118 relationships. This choice (instead of normal ICP) is based on the fact that in the data 119 preparation step, we only select significant miRNAs and mRNAs as the input of ICP.
120
Therefore in the corresponding dataset, there might be hidden miRNAs which are 121 regulators of mRNAs. In our application of hidden ICP, the set of significant miRNAs 122 are considered as the predictor variables. Then for each mRNA (the target or response 123 variable), hidden ICP is used to find the direct causes, i.e. the miRNAs which regulate 124 of the mRNA. In addition, we use Pam50 [21] to categorise the samples into different 125 subtypes, and consider the subtypes as the environments used in hidden ICP.
126

Implementation
127
The above algorithm has been implemented and integrated into the R package 128 miRLAB [23] . In addition, the R scripts for reproducing the results of experiments in 129 this paper are also available upon request.
130
Functional annotation of miRNAs 131 We do enrichment analysis for miRNA targets to annotate biological functions of 132 miRNAs. We apply GO [24] , KEGG [25] , Reactome [26] and DisGeNET [27] for the top 133 target genes based on the point estimator for the causal effects of each miRNA 134 identified by hiddenICP using Pam50 (hiddenICP-Pam50). Since the enrichment 135 analysis results of hundreds of target genes are too general to gain biological insight, we 136 only focus on the enrichment analysis of the top 50 target genes for each miRNA.
Results and discussion
138
The predicted results of miRNA-mRNA regulation relationships are validated with the 139 transfection data [23] , which can be found in S4 File. In addition, the experimentally 140 confirmed databases are also used for the validation of the results, including miRTarbase 141 version 6.1 [28] , TarBase version 7.0 [29] , and miRWalk version 2.0 [30] . The confirmed 142 miRNA-mRNA interactions retrieved from these databases are available in S5 File.
143
Comparation of results
144
To evaluate the performance of hidden ICP, we have used the other 4 methods in our 145 experiments for comparison, including idaFast [17] in pcalg package [31] , 146 jointIDA direct [32] , Pearson [33] and Lasso [34] . idaFast is a function which is used to 147 estimate total causal effect of one variable on various target variables. jointIDA With hidden IPC, we run it in two separate scenarios. In the first scenario, we 155 randomly divide the samples into three datasets, each corresponding to an environment. 156 In the second scenario, Pam50 [21] is used to categorise the samples based on different 157 cancer subtypes, including Basal, Her2, LumA, LumB, and Normal-like, to create 158 datasets for the different environments. interactions. To have a comprehensive analysis, we select the top 500, 1,000, 1,500, and 163 2,000 miRNA-mRNA interactions for the validation, and we also do the validation with 164 respect to each miRNA by selecting the top 50, 100, 150 and 200 interactions in which 165 the miRNA is involved. First of all, we validate the results of the 6 methods by using the transfection data 167
June 2, 2018 6/15 as the ground truth. As the miRNAs in the transfection data are not complete, for this 168 case, it is not fair to compare the top miRNA-mRNA interactions for all miRNAs. the Borda function in the package miRLAB [23] to integrate Pearson [33] , Lasso [34] 195 with others to generate ensembles for predicting miRNA-mRNA interactions. This significance p-value is calculated as follows:
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hsa In this section, we conduct GO [24] , KEGG [25] , Reactome [26] and DisGeNET [27] 222 enrichment analysis of top target genes for each miRNA identified by hiddenICP-Pam50. 223 Since the enrichment analysis results of hundreds of target genes are too general to gain 224 biological insight, we only focus on the enrichment analysis of the top 50 target genes 225 for each miRNA. In Table 1 obtained from intervention experiments), and it is based on the invariance assumption 246 of the causal relationships across different settings. The method has been designed with 247 high dimensional data in mind and has an extension for hidden variables. These 248
